Authors:
Huck, C
Endl, J
Walk, T
Noessner, E
Jung, G
Wank, R
Schendel, DJ
Citation: C. Huck et al., HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex, DIABETOLOG, 44(1), 2001, pp. 70-80
Authors:
Peakman, M
Tree, TI
Endl, J
van Endert, P
Atkinson, MA
Roep, BO
Citation: M. Peakman et al., Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1diabetes - Report of phase II of the second international immunology of diabetes society workshop for standardization of T-cell assays in type 1 diabetes, DIABETES, 50(8), 2001, pp. 1749-1754
Authors:
Beales, PE
Liddi, R
Endl, J
Kientsch-Engel, R
Pozzilli, P
Citation: Pe. Beales et al., Intradermal administration of GAD & evaluation of diabetes incidence in mice: Possible relevance for skin tests in humans, AUTOIMMUN, 32(2), 2000, pp. 109-113
Authors:
Kolm-Litty, V
Berlo, S
Bonifacio, E
Bearzatto, M
Engel, AM
Christie, M
Ziegler, AG
Wild, T
Endl, J
Citation: V. Kolm-litty et al., Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen, J IMMUNOL, 165(8), 2000, pp. 4676-4684